CoChat

Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives

Open access

The DOI matches its Crossref record; 121 of the 123 references it cites were found in a registry or an index.

Abstract

The vasculature is a key player and regulatory component in the multicellular microenvironment of solid tumors and, consequently, a therapeutic target. In colorectal carcinoma (CRC), antiangiogenic treatment was approved almost 20 years ago, but there are still no valid predictors of response. In addition, treatment resistance has become a problem. Vascular heterogeneity and plasticity due to species-, organ-, and milieu-dependent phenotypic and functional differences of blood vascular cells reduced the hope of being able to apply a standard approach of antiangiogenic therapy to all patients. In addition, the pathological vasculature in CRC is characterized by heterogeneous perfusion, impaired barrier function, immunosuppressive endothelial cell anergy, and metabolic competition-induced microenvironmental stress. Only recently, angiocrine proteins have been identified that are specifically released from vascular cells and can regulate tumor initiation and progression in an autocrine and paracrine manner. In this review, we summarize the history and current strategies for applying antiangiogenic treatment and discuss the associated challenges and opportunities, including normalizing the tumor vasculature, modulating milieu-dependent vascular heterogeneity, and targeting functions of angiocrine proteins. These new strategies could open perspectives for future vascular-targeted and patient-tailored therapy selection in CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers16050890

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The tumor-related vascular structure and hierarchy determine the surgical resection strategy used for colorectal cancer. Surgical preparation after right hemicolectomy with complete mesocolic excision because of cecal carcinoma (circle). Central ligation of the ileocolic vessels (artery and vein) and the right colic artery (dashed lines) ensures resection of the regional lymph nodes, which is well known to improve survival.
Figure 1 The tumor-related vascular structure and hierarchy determine the surgical resection strategy used for colorectal cancer. Surgical preparation after right hemicolectomy with complete mesocolic excision because of cecal carcinoma (circle). Central ligation of the ileocolic vessels (artery and vein) and the right colic artery (dashed lines) ensures resection of the regional lymph nodes, which is well known to improve survival.CC BY · PubMed Central
Figure 2 Different types of vessels are present in human colorectal cancer tissues. In human CRC, blood vessels can be labeled using the markers CD31 or vWF. Lymphatic vessels may be stained with LYVE-1 or podoplanin. Arteries and veins can be differentiated by labeling using the artery marker ephrinB2. This may be complemented by morphological differentiation of arteries (A) and veins (V) together with analysis of milieu-dependent expression of vessel markers such as SPARCL1. CD31, vWF, LYVE-1 and podoplanin panels: 25x objective; ephrinB2 and SPARCL1 panels: scale bars corresponding to 50 µm. The vWF panel is modified from Schellerer et al., Lab Invest 2007 [97].
Figure 2 Different types of vessels are present in human colorectal cancer tissues. In human CRC, blood vessels can be labeled using the markers CD31 or vWF. Lymphatic vessels may be stained with LYVE-1 or podoplanin. Arteries and veins can be differentiated by labeling using the artery marker ephrinB2. This may be complemented by morphological differentiation of arteries (A) and veins (V) together with analysis of milieu-dependent expression of vessel markers such as SPARCL1. CD31, vWF, LYVE-1 and podoplanin panels: 25x objective; ephrinB2 and SPARCL1 panels: scale bars corresponding to 50 µm. The vWF panel is modified from Schellerer et al., Lab Invest 2007 [97].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 121 references

Research works printed but not linked: 1

  1. Vincent, S.H., De Vita, T., and Rosenberg, S.A. (2001). Antiangiogenesis Agents, in Cancer: Principles and Practice of Oncology, Lippincott Williams & Wilkins Publishers.

Cited by

See all 11

Metadata

Authors
Jacobsen, A., Siebler, J., Grützmann, R., Stürzl, M., & Naschberger, E.
Affiliations
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Corresponding author
Naschberger, Elisabeth
Venue
Cancers
Publisher
MDPI AG
Published
2024-02-22
Volume
16
Issue
5
Pages
890
ISSN
2072-6694 (ISSN-L)
OpenAlex
W4392101799
Cited by
11
References
123
Citations by year
2026: 3 · 2025: 6 · 2024: 2
FWCI
0.45
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • German Research Foundation (DFG) FOR 2438, subproject 2 (280163318, 375876048, 437201724, 429280966, 493624887)
  • DFG SFB/TRR 241, subproject A06 (280163318, 375876048, 437201724, 429280966, 493624887)
  • DFG STU 238/10-1 (280163318, 375876048, 437201724, 429280966, 493624887)
  • DFG TRR 305, subproject B08 (280163318, 375876048, 437201724, 429280966, 493624887)
  • DFG-NOTICE program (280163318, 375876048, 437201724, 429280966, 493624887)
  • W. Lutz Stiftung (280163318, 375876048, 437201724, 429280966, 493624887)
  • Forschungsstiftung Medizin am Universitätsklinikum Erlangen (280163318, 375876048, 437201724, 429280966, 493624887)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
colorectal cancer, anti-angiogenic therapy, tumor vasculature, vascular heterogeneity, tumor microenvironment, vascular normalization, treatment resistance, predictive biomarkers, vascular-targeted therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives. https://app.cochat.ai/papers/10.3390/cancers16050890
The paper
Jacobsen, A., Siebler, J., Grützmann, R., Stürzl, M., & Naschberger, E. (2024). Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives. Cancers. https://doi.org/10.3390/cancers16050890

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.